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METHOD: Inappropriate geriatric medications were
deﬁned by well accepted explicit criteria. Logistic models
were employed to estimate the likelihood functions using
the 1996 Medical Expenditure Panel Survey (MEPS),
based on a national representative sample of the non-
institutionalized populations. Complex survey sample
design was adjusted in modeling.
RESULTS: When grouping all types of insurance together,
a dichotomous insurance variable captured no difference
in the likelihood of inappropriate medication use between
the insured and the uninsured groups. After distinguish-
ing the insurance type, it was found that the elderly 
with fee-for-service (FFS) coverage were more likely to 
use inappropriate prescriptions (OR = 1.73, 95% CI:
1.27–2.34), compared to those without coverage. This
effect was reduced but remained signiﬁcant after control-
ling for the total number of prescriptions (OR = 1.39,
95% CI: 1.01–1.90). In contrast, people with HMO type
of coverage were indifferent with the uninsured. More-
over, as expected, the most predictive variable of inap-
propriate prescriptions is the total number of medication
use, followed by worse health conditions and women.
CONCLUSION: When analyzing insurance impact on
drug utilization, distinguishing insurance type seemed to
be important. This study suggested a higher risk with FFS
model for inappropriate medication use compared to the
uninsured and others, the ﬁrst evidence of its kind based
on a national database. While this ﬁnding offers some
interesting implications for insurance policies, further
research is warranted to discern the reasons for the
observed adverse impact of FFS coverage.
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OBJECTIVE: The general practitioner is often the ﬁrst
professional involved in the treatment of tobacco depen-
dence, when he or she responds to the explicit request of
smokers to help end their tobacco consumption or asks
his or her patients about their situation in relation to
tobacco.
METHOD: The STOP programme, through a ques-
tionnaire distributed to around 6,000 doctors, aims to
describe the progress doctors are making with regard to
their own tobacco dependence as well as in the public
health initiative entrusted to them.
RESULTS: Here we present the preliminary results of this
investigation, through the analysis of the ﬁrst 300 ques-
tionnaires. The average age of our sample was 45 years;
75% were men. For 41% of the doctors that responded,
the setting up of a treatment programme takes place
during a speciﬁc consultation. The information supports
used come from the pharmaceutical industry (62%),
health insurance companies and anti-smoking associa-
tions (38%). 82% felt that the most relevant support was
patient information that they could distribute and that
would back up verbal advice. If 51% of doctors state that
they have never smoked, 62% of the smokers expressed
a desire to give up smoking, and 85% of them do not
consider their status as smokers as a hindrance to begin-
ning smoking cessation treatment with their patients.
Lack of training (3%), skepticism as to the effectiveness
of available treatments (4%), the absence of speciﬁc
remuneration (4%), do not seem to be the reasons for 
not beginning smoking cessation treatment with their
patients, unlike lack of time (49%) and patient resistance
(41%).
CONCLUSION: First professional involved, the general
practitioner should thus be recognised as a real partner
in Health policy and improve their commitment with it.
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Positive clinical outcomes are dependent on patients
adhering to their treatment plans. Improving patients’
medication compliance through a mail-based medication
support program that promotes preferred formulary
agents leads to improved clinical outcomes. It also results
in a win-win-win situation for patients, payers and indus-
try partners by increasing appropriate and cost-effective
utilization.
OBJECTIVES: This study assesses the effectiveness of 
a mail-based medication support program designed to
increase prescription reﬁll rates for selected maintenance
medications. All patients taking selected medications 
are sent a welcome package. Patients late in reﬁlling their
prescriptions are sent a reminder letter. Patients who do
not reﬁll are sent a second reminder letter. Patients 
who remain non-compliant may be called by a nurse case
manager. Patients who reﬁll a new prescription on a
timely basis are sent a congratulations letter.
METHODS: In phase one, reﬁll rates for patients receiv-
ing one or more reﬁll reminder letters are compared with
the reﬁll rates for a comparison sample of patients who
did not receive reminder letters. In phase two, to be com-
pleted Q1 2002, we will compare the reﬁll rates and cost
proﬁles between selected medications and a similar class
of unselected medications.
RESULTS: Phase one results show that patients who
received reminder letters proceeded to have 14,731 ﬁlls,
537,321 units for 431,200 days supply. This compares to
the control group, which had 10,329 ﬁlls, 376,736 units
for 302,331 days supply. The difference between the
groups shows that the intervention produced 4,403 ﬁlls,
160,585 units for 128,870 days supply.
CONCLUSIONS: Initial results show that a mail-based
medication reﬁll reminder program is an effective means
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of improving reﬁll rates. This leads to improved medica-
tion compliance and improved clinical outcomes. Because
selected medications were also formulary-preferred
agents, formulary compliance and volume within several
key therapeutic categories was enhanced.
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OBJECTIVES: To compare survival in sedated ICU
patients by hospital type and to investigate various factors
associated with patient survival.
METHODS: Data from 622 patients admitted to the
ICU, intubated more than 24 hours, and receiving seda-
tives/analgesics during intubation were collected from 
42 hospitals from November 22, 1999 to March 4, 2000.
Patient demographic, sedative and analgesic selection,
and outcome data were recorded on standard data forms.
The Kaplan-Meier (KM) survival curves and the Cox pro-
portional hazard model were used to examine the effect
of hospital type and other factors on patient survival.
RESULTS: Patients in teaching hospitals had a signiﬁ-
cantly higher survival rate compared to community hos-
pitals (p < 0.02). The Cox regression analyses showed
that patient mortality was signiﬁcantly associated with
older age (hazard ratio; HR = 1.03), higher severity of
illness (HR = 1.04), having certain comorbid conditions
[lymphoma (HR = 2.87) and chronic hypoxia (HR =
2.57)], receiving analgesic agents (e.g., morphine, hydro-
morphone, and fentanyl) (HR = 2.76) and receiving care
in a community hospital (HR = 0.62). However, whether
the patient received treatment consistent with practice
guidelines for ICU sedation and was treated in a hospital
with a care plan for ICU sedation had no signiﬁcant
impact on patient survival in this analysis.
CONCLUSIONS: The results suggest that patients 
admitted to teaching hospitals seem to have better sur-
vival compared to community hospitals controlling for
other factors that impact patient outcomes. However,
whether this is due to hospital type, some other patient
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OBJECTIVE: This evidence-based review evaluates the
therapeutic interchangeability of levothyroxine between
the original product Synthroid, and the two major 
generic brands Levoxyl and Levothroid, for use in
hypothyroidism.
METHODS: A literature search identiﬁed 8 bioequiva-
lence trials comparing different formulations of levothy-
roxine tablets. Meta-analyses were conducted to compare
average bioavailability using three pharmacokinetic mea-
sures (Total T4, Thyrotropin-stimulating Hormon [TSH],
and Free Thyroxine Index [FTI]). These measures were
also evaluated for differences in variability between treat-
ment groups.
RESULTS: The three formulations of Synthroid, Levoxyl,
and Levothroid can be expected to produce similar
average levels of circulating total T4 and TSH at steady
state. Due to limited data, this statement does not extend
to levels of free T4 nor free T3. Meta-analyses suggest
that differences may exist in the variability of effect 
of levothyroxine products. Speciﬁcally, individual TSH
levels in treated hypothyroid patients may span a wider
range with some products than with others. This vari-
ability may be due to true individual differences in the
variability of absorption of these products or to the use
of outdated assay techniques (ﬁrst generation radio-
immunoassay) and short study durations that do not
allow enough time for the patient to reach steady-state.
CONCLUSION: Studies generally suggest that Synthroid,
Levoxyl, and Levothroid are bioequivalent on average.
However, population (between subject) variability may 
be different across products. Establishment of individual
bioequivalence will require new, prospective studies of
adequate treatment duration that use the most sensitive
assay methodologies. Until such studies are undertaken,
current treatment guidelines that recommend hypo-
thyroid patients be reassessed 6 weeks after a change 
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OBJECTIVES: The American Productivity Audit (APA),
an on-going week-to-week telephone survey, provides
valid and reliable estimates of health-related work loss.
The APA is currently being used to generate tailored
reports for employers to inform them of the lost produc-
tive work time associated with speciﬁc health conditions.
The paper illustrates the process.
METHODS: We developed and validated the Work and
Health Interview (WHI) for APA administration. The
WHI quantiﬁes missed work hours and lost productive
time while at work for speciﬁc health conditions using
